VIKING GLOBAL PERFORMANCE LLC

CIK 1132625 · last filed 2019-06-28

VIKING GLOBAL PERFORMANCE LLC is a corporate insider who has filed 4 SEC Form 4 insider transactions across 2 companies since 2019. The most recent filing, for BBIO, was dated Jun 28, 2019. Across all open-market trades the lifetime net is +$563.4M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $850.2M across reported positions. The firm reports its address in Greenwich, CT. 40 SEC filings were submitted jointly with Viking Global Equities II LP.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$850.17M

Companies

2

Total Filings

4

Lifetime Open-Market Net

$563.40M

Filer Profile

Reported Address

55 RAILROAD AVENUE
3RD FLOOR
GREENWICH, CT 06830

Phone

(203) 863-5000

Formerly Known As

VIKING GLOBAL PERFORMANC LLC (2001–2004)

Related Filers

Viking Global Equities II LP — 40 joint filings, latest 2024-06-18

Viking Long Fund GP LLC — 39 joint filings, latest 2023-06-26

Viking Long Fund Master Ltd. — 39 joint filings, latest 2023-06-26

OLE ANDREAS HALVORSEN — 32 joint filings, latest 2024-06-18

David C. Ott — 32 joint filings, latest 2024-06-18

Viking Global Equities LP — 30 joint filings, latest 2019-07-12

Rose Sharon Shabet — 28 joint filings, latest 2024-06-18

Viking Global Equities Master Ltd. — 27 joint filings, latest 2024-06-18

Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
BBIO	10%+ Owner	11,736,137	$72.44	$850.17M	$560.00M	1	2019-06-28
Urovant Sciences Ltd. (UROV) Delisted	10%+ Owner	22,819,798	$16.24	$370.59M	$3.40M	2	2019-06-11

Recent Filings

4 filings

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2019-06-28	BBIO	Mixed	+186,346,937	$560.00M	EDGAR
2019-06-11	Urovant Sciences Ltd. (UROV) Delisted	Buy (P)	+213,380	$1.77M	EDGAR
2019-05-20	Urovant Sciences Ltd. (UROV) Delisted	Buy (P)	+216,080	$1.63M	EDGAR
2019-03-19	—	Buy (P)	+66,666,670	$100.00M

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.